<section class="bg-custom-gray-200 py-3 md:py-12">
    <div class="container">
        <h1 class="text-[28px] md:text-[44px] font-bold md:text-center mb-2">Creating a Better Way to Treat Cancer</h1>
        <div class="grid grid-cols-1 lg:grid-cols-12 gap-6">
            <div class="lg:col-span-6">
                <div class="[&>p]:text-[15px] [&>p]:font-normal [&>p]:leading-[23px] [&>p]:mt-5 [&>p]:tracking-normal">
                    <h2 class="text-2xl md:text-3xl font-medium mt-6 mb-2"> Using the Body's Immune System to Treat Cancer</h2>
                    <div class="block lg:hidden my-6 lg:my-0">
                        <div class="rounded-2xl overflow-hidden">
                            <a href="https://www.youtube.com/watch?v=QNFte4x413Y" target="_blank">
                                <img src="assets/images/offer-hero-img.png" alt="hero">
                            </a>
                            <div class="text-center text-base font-normal underline cursor-pointer mt-2">4 Reasons to invest</div>
                        </div>
                    </div>
                    <p> CancerVax is a pre-clinical biotech company working with a world-class team of experienced cancer researchers and physicians at UCLA to create a breakthrough Universal Cancer Treatment platform (UCV).</p>
                    <p> Our cancer treatment is designed to be customizable, administered as a shot, and leverage state-of-the-art bioengineering and molecular technologies.</p>
                    <p> This innovative approach detects, marks, and kills cancer cells exclusively. By inducing cancer cells to express a distinct marker absent in healthy cells, custom antibody drugs and the body's immune cells can precisely target and eradicate cancer cells.</p>
                </div>
                <div class="flex justify-center mt-12">
                    <a href="#" class="inline-block text-lg font-semibold w-full md:w-1/2 uppercase cursor-pointer text-center rounded-2xl !p-2 bg-[#ffa41b] !border-[#b76e00] !border-b-[6px]">Invest Now</a>
                </div>
            </div>
            <div class="lg:col-span-6 hidden lg:flex items-center min-h-full max-w-[500px]">
                <div class="rounded-2xl overflow-hidden">
                    <a href="https://www.youtube.com/watch?v=QNFte4x413Y" target="_blank">
                        <img src="assets/images/offer-hero-img.png" alt="hero">
                    </a>
                    <div class="text-center text-base font-normal underline cursor-pointer mt-2">4 Reasons to invest</div>
                </div>
            </div>
        </div>
    </div>
</section>

    <!-- 2nd Section -->
<section class="py-3 md:py-12">
    <div class="container">
        <div class="grid grid-cols-1 lg:grid-cols-12 gap-6">
            <div class="lg:col-span-6">
                <h3 class="text-[26px] md:text-[32px] font-medium mt-6 mb-12">Reasons to Invest</h3>
                <div class="[&_p]:text-[15px] [&_p]:font-normal [&_p]:leading-[23px] [&_p]:tracking-normal [&_span]:font-semibold">
                    <div class="flex flex-col md:flex-row gap-4 mb-10">
                        <div class="text-white bg-custom-teal-100 text-xl font-semibold rounded-md mt-[2px] max-w-[45px] min-w-[45px] max-h-10 text-center leading-10">1</div>
                        <p>According to the American Cancer Society,<span> cancer is the second leading cause of death in the United States in 2022,</span> more than COVID deaths. According to Fortune Business Insights, the global cancer drugs market is projected to grow from $205 billion in 2023 to <a href="#" class="text-blue-700 font-semibold">$484 billion by 2030</a></p>
                    </div>
                    <div class="flex flex-col md:flex-row gap-4 mb-10">
                        <div class="text-white bg-custom-teal-100 text-xl font-semibold rounded-md mt-[2px] max-w-[45px] min-w-[45px] max-h-10 text-center leading-10">2</div>
                        <p>Cancer affects many lives as the second leading cause of death in the US. While we don’t have a solution to prevent cancer, our objective is to develop our Universal Cancer Treatment platform so that it can be customized to treat a broad spectrum of cancer types and substantially decrease the number of cancer-related fatalities.</p>
                    </div>
                    <div class="flex flex-col md:flex-row gap-4 mb-10">
                        <div class="text-white bg-custom-teal-100 text-xl font-semibold rounded-md mt-[2px] max-w-[45px] min-w-[45px] max-h-10 text-center leading-10">3</div>
                        <p>CancerVax is proud to be working with a world-class team of experienced cancer researchers and physicians at UCLA. This team of MDs and PhDs has 80+ years of combined experience in cancer research and clinical treatment. Combined with the strong management team at CancerVax, we are undertaking bold and innovative immunotherapy research approaches to create a better way to treat cancer.</p>
                    </div>
                    <div class="flex flex-col md:flex-row gap-4 mb-10">
                        <div class="text-white bg-custom-teal-100 text-xl font-semibold rounded-md mt-[2px] max-w-[45px] min-w-[45px] max-h-10 text-center leading-10">4</div>
                        <p>CancerVax has previously raised over <span>$3.3 million in funding.</span></p>
                    </div>
                </div>
            </div>
            <div class="hidden lg:block lg:col-span-6 ralative">
                <div class="bg-custom-gray-100 sticky top-[300px] my-12 mx-auto max-w-[370px] rounded-[20px] p-5">
                    <div class="flex justify-center">
                        <a href="#" class="inline-block text-lg font-semibold w-full uppercase cursor-pointer text-center rounded-2xl !p-2 bg-[#ffa41b] !border-[#b76e00] !border-b-[6px]">Invest Now<span class="block text-center text-xs uppercase font-medium">Secure Direct Invest Platform</span></a>
                    </div>
                    <div class="flex justify-between mt-10">
                        <div>
                            <p class="text-base font-normal">PRICE</p>
                            <p class="text-lg font-semibold mt-2 mb-5">$2.10</p>
                            <p class="text-base font-normal">BONUS SHARES</p>
                            <p class="text-lg font-semibold mt-2 mb-5">Up to 30%</p>
                        </div>
                        <div>
                            <p class="text-base font-normal">MINIMUM</p>
                            <p class="text-lg font-semibold mt-2 mb-5">$525.00 </p>
                            <p class="text-base font-normal">OFFERING CIRCULAR </p>
                            <p class="text-lg font-semibold mt-2 mb-5">See on SEC.gov</p>
                        </div>
                    </div>
                    <div class="max-w-[215px] mx-auto mt-2">
                        <p class="font-semibold text-lg text-center">BROKER DEALER</p>
                        <img src="assets/images/DallMore.png" alt="hero">
                    </div>
                </div>
            </div>
        </div>
    </div>
</section>

    <!-- 3rd Section -->
<section class="py-3 md:py-12">
    <div class="container">
        <div class="lg:w-1/2">
            <h3 class="text-[26px] md:text-[32px] font-medium mt-6 mb-12">
                The Problem & Our Solution - Universal Cancer Treatment Platform
            </h3>
        </div>
        <div class="grid grid-cols-1 lg:grid-cols-12 gap-6">
            <div class="lg:col-span-6">
                <h4 class="text-[23px] md:text-[26px] font-medium leading-none mb-2"> Help Millions Get Better, Without Feeling Worse</h4>
                <p class="text-[17px] font-normal leading-[23px] mt-5 tracking-normal"> Cancer is the second leading cause of death in the United States – responsible for more than 1.9 million diagnosed cases and 609,360 deaths in 2022.</p>
            </div>
            <div class="lg:col-span-6 flex justify-center items-center">
                <img src="assets/images/solution1.png" alt="hero" class="">
            </div>
        </div>
        <div class="grid grid-cols-1 lg:grid-cols-12 gap-6">
            <div class="lg:col-span-6">
                <p class="text-[17px] font-normal leading-[23px] mt-5 tracking-normal">Current cancer treatments still haven’t progressed past the options of surgery, chemotherapy, and radiation, which have extreme, life-long side effects. In addition to being toxic and harmful, treatments like chemotherapy can be very expensive.</p>
            </div>
            <div class="lg:col-span-6 flex justify-center items-center">
                <img src="assets/images/solution2.png" alt="hero" class="">
            </div>
        </div>
        <div class="grid grid-cols-1 lg:grid-cols-12 gap-6">
            <div class="lg:col-span-6">
                <p class="text-[17px] font-normal leading-[23px] mt-5 tracking-normal"> Cancer immunotherapy is the next generation weapon in the fight against cancer.  It uses the body’s own immune system to target and kill cancer cells. </p>
                <p class="text-[17px] font-normal leading-[23px] mt-10 tracking-normal">Working with the world-class research team at UCLA, CancerVax is developing a Universal Cancer Treatment platform to target and destroy cancer cells with precision.</p>
            </div>
            <div class="lg:col-span-6 flex justify-center items-center">
                <img src="assets/images/solution3.png" alt="hero" class="">
            </div>
        </div>
    </div>
</section>

    <!-- 4th Section -->
<section class="py-3 md:py-12">
    <div class="container">
        <div class="[&>p]:text-[17px] [&>p]:font-normal [&>p]:leading-[23px] [&>p]:mt-5 [&>p]:tracking-normal [&_span]:font-semibold">
            <h4 class="text-[23px] md:text-[32px] font-medium leading-none mb-6">Our Development Pipeline</h4>
            <div>
                <img src="assets/images/opd-ucla-offer.png" alt="hero" class="w-full">
                <div class="text-center underline text-base font-normal cursor-pointer">Our Development Pipeline</div>
            </div>
            <p>In recent years, advances in science and biotechnology have proven that the body’s immune system is very effective at targeting and killing abnormal cells, germs and viruses, and has been doing it since the beginning of time. The problem is that cancer is not a foreign invader and grows much faster than the body’s normal immune response rate.</p>
            <p>Much like COVID-19 vaccines that train the body to recognize and destroy the coronavirus, cancer immunotherapies can train the body to target and destroy specific cancer cells. <span> Cancer immunotherapies are also known as cancer treatment vaccines.</span> </p>
            <p>While there is no such thing as a magic vaccine that can prevent people from getting cancer, we can borrow many of the techniques and technologies from modern preventative flu or COVID vaccines, and use the body’s immune system to target and treat cancers.</p>
            <p>Our immunotherapy technologies being developed at UCLA are designed to be delivered as simple injections. With our development of a Universal Cancer Treatment platform, we look forward to the day when treating cancer will be as simple as getting a flu shot – <span>We believe immunotherapy is a better way to treat cancer.</span></p>
            <p>CancerVax has exclusive rights to license and commercialize the technology and patents that result from these UCLA research programs.</p>
            <h5 class="text-[23px] md:text-[32px] font-medium leading-none mt-12 mb-4">Additional Immunotherapy Projects</h5>
            <p>In addition to our Universal Cancer Treatment platform, we are also working with UCLA to create two other immunotherapy technologies.</p>
            <div class="flex items-center lg:justify-between flex-col lg:flex-row">
                <h4 class="text-[23px] md:text-[32px] font-medium leading-none mt-14 mb-9">Universal CAR-T Cell Platform (UCAR-T)</h4>
                <div class="w-full md:w-fit">
                    <a href="#" class="text-white bg-custom-teal-100 text-base text-center font-semibold rounded-md px-6 py-3 w-full block">Learn More</a>
                </div>
            </div>
            <p>Our UCAR-T Cell platform is a novel and customizable low-cost cancer treatment platform, delivered as a shot, that can reprogram natural immune T-cells inside the body to seek and destroy targeted cancer cells. These modified T-cells are called Chimeric Antigen Receptor (CAR) T Cells. Conventional CAR-T Cell therapy can cost more than $500,000 per dose due to complicated and expensive lab processes. Our goal is to lower the cost to a few thousand dollars per dose by helping the body make its own CAR T-cells.</p>
            <p>Our Universal Cancer Treatment platform and our UCAR-T Cell platform can be used separately, however, when used together, we believe that we can kill cancer cells with extreme precision using the body’s immune system at very low costs. Our Universal Cancer Treatment platform detects and marks a unique target our UCAR-T Cell platform makes T-cells that attack that target.</p>
        </div>
        <div class="grid grid-cols-1 lg:grid-cols-12 gap-6 mt-5">
            <div class="lg:col-span-6">
                <img src="assets/images/pipeline-virus-left.jpg" alt="hero" class="">
            </div>
            <div class="lg:col-span-6">
                <img src="assets/images/pipeline-virus-right.jpg" alt="hero" class="">
            </div>
        </div>
        <div class="my-8 md:my-24">
            <div class="flex items-center justify-between gap-6 flex-col md:flex-row">
                <div class="underline text-lg font-semibold cursor-pointer">
                    Children’s Cancer
                </div>
                <div class="w-full md:w-fit">
                    <a href="#" class="text-white bg-custom-teal-100 text-base text-center font-semibold rounded-md px-6 py-3 w-full block" >Learn More</a>
                </div>
            </div>
            <div class="grid grid-cols-1 lg:grid-cols-12 gap-6 mt-8">
                <div class="lg:col-span-8 order-2 lg:order-1 [&>p]:text-[17px] [&>p]:font-normal [&>p]:leading-5 [&>p]:mb-5 [&>p]:tracking-normal">
                    <p>We are creating a disease-specific immunotherapy targeted at treating Ewing sarcoma, a rare but deadly bone and soft tissue cancer that affects children and young adults. Unfortunately, the death rate for patients with recurrent Ewing sarcoma is nearly 100%.</p>
                    <p>All our immunotherapy technologies are designed to be delivered as simple injections. We look forward to the day when treating cancer will be as simple as getting a flu shot – a better way to treat cancer.</p>
                </div>
                <div class="lg:col-span-4 order-1 lg:order-2"><img src="assets/images/girl_cancervax.jpg" alt="hero" class="rounded-[10px]"></div>
            </div>
        </div>
        <div class="bg-custom-gray-200 rounded-[20px] px-2 py-10 md:px-12 md:py-12">
            <div class="text-custom-teal-100 text-xl md:text-[28px] font-semibold mb-2 text-center">
                $183 Billion
            </div>
            <div class="flex justify-center">
                <div class="text-lg md:text-[26px] text-center font-medium mb-12 relative">
                    <span>U.S. cancer healthcare spend in 2015</span>
                    <span class="hidden lg:block text-base absolute -top-[15px] -right-[20px]">(4)</span>
                </div>
            </div>
            <div class="text-custom-teal-100 text-xl md:text-[28px] font-semibold mb-2 text-center">
                $246 Billion
            </div>
            <div class="flex justify-center">
                <div class="text-lg md:text-[26px] text-center font-medium mb-12 relative">
                    <span>Projected U.S. cancer healthcare spend by 2030</span>
                    <span class="hidden lg:block text-base absolute -top-[15px] -right-[20px]">(4)</span>
                </div>
            </div>
            <div class="text-custom-teal-100 text-xl md:text-[28px] font-semibold mb-2 text-center">
                $484 Billion
            </div>
            <div class="flex justify-center">
                <div class="text-lg md:text-[26px] text-center font-medium mb-12 relative">
                    <span>Projected global cancer drugs market by 2030</span>
                    <span class="hidden lg:block text-base absolute -top-[15px] -right-[20px]">(2)</span>
                </div>
            </div>
            <div class="text-custom-teal-100 text-xl md:text-[28px] font-semibold mb-2 text-center">
                $3.2 Trillion
            </div>
            <div class="flex justify-center">
                <div class="text-lg md:text-[26px] text-center font-medium mb-12 relative">
                    <span>Projected global biotechnology market by 2030</span>
                    <span class="hidden lg:block text-base absolute -top-[15px] -right-[20px]">(5)</span>
                </div>
            </div>
        </div>
        <div class="my-8 md:my-12">
            <h6 class="text-[23px] md:text-[28px] font-medium leading-none">The Market</h6>
            <h4 class="text-[23px] md:text-[42px] font-bold leading-none mt-3 mb-3 md:mb-12">Meeting A Growing Critical Need</h4>
            <div class="[&_p]:text-[17px] [&_p]:font-normal [&_p]:leading-[23px] [&_p]:mb-5 [&_p]:tracking-normal">
                <div class="grid grid-cols-1 lg:grid-cols-12 gap-6">
                    <div class="lg:col-span-4">
                        <div class="text-white bg-custom-teal-100 text-xl font-semibold rounded-md mb-3 max-w-[45px] min-w-[45px] max-h-10 text-center leading-10">1</div>
                        <p>Currently, there are over 100 types of cancers. In 2015 approximately $183 billion was spent on cancer health care, in the U.S. alone; that number is projected to grow to $246 billion by 2030. (4)</p>
                    </div>
                    <div class="lg:col-span-4">
                        <div class="text-white bg-custom-teal-100 text-xl font-semibold rounded-md mb-3 max-w-[45px] min-w-[45px] max-h-10 text-center leading-10">2</div>
                        <p>The global oncology drugs market is projected to grow from $205 billion in 2023 to $484 billion by 2030. (2)</p>
                    </div>
                    <div class="lg:col-span-4">
                        <div class="text-white bg-custom-teal-100 text-xl font-semibold rounded-md mb-3 max-w-[45px] min-w-[45px] max-h-10 text-center leading-10">3</div>
                        <p>The global biotechnology market is projected to grow from $1.3 trillion in 2023 to $3.2 trillion by 2030. (5)</p>
                    </div>
                </div>
                <div class="mt-12">
                    <p>CancerVax is working with UCLA to develop breakthrough immunotherapy cancer treatments that use the body's immune system to treat cancer. The company also has exclusive rights to license new intellectual property that may be developed by UCLA under research programs, which offers other potential revenue streams.</p>
                </div>
            </div>
        </div>
    </div>
</section>

    <!-- 5th Section -->
<section class="py-3 md:py-12">
    <div class="container">
        <div class="hidden md:block">
            <img src="assets/images/Investor_Growth.jpg" alt="hero" class="w-full">
        </div>
        <div class="md:hidden">
            <img src="assets/images/Mobile_Growth.png" alt="hero" class="w-full">
        </div>
        <h4 class="text-[23px] md:text-[32px] font-medium mt-5 md:mt-12 lg:mt-24 mb-0 md:mb-5 lg:mb-12">Why Invest</h4>
        <div class="grid grid-cols-1 lg:grid-cols-12 gap-6 mt-5 mb-7">
            <div class="lg:col-span-6">
                <h5 class="text-xl md:text-[26px] font-medium leading-none mb-2">Let's Beat Cancer</h5>
                <p class="text-[17px] font-normal leading-[23px] mb-5 tracking-normal">Pharmaceutical research is booming from the effects of the COVID-19 pandemic, where the medical community learned how to use mRNA to recognize and fight specific disease states. A similar concept is being applied by CancerVax to create immunotherapy treatments with the purpose of using a patient’s immune system to detect, mark, and kill cancer.</p>
            </div>
            <div class="lg:col-span-6"> <img src="assets/images/invest-microscope.png" alt="hero" class="w-full"></div>
        </div>
        <div>
            <div class="grid grid-cols-1 lg:grid-cols-12 gap-6 mt-5 [&_p]:text-[17px] [&_p]:font-normal [&_p]:leading-[23px] [&_p]:mb-5 [&_p]:tracking-normal">
                <div class="lg:col-span-6">
                    <p> The CancerVax business model involves partnering with experienced cancer research institutions, like UCLA, to develop new life-changing drugs, followed by plans to license and/or sell the company’s drugs, or license technologies to major pharmaceutical companies. <br><br> As a biotech company, CancerVax’s goal is to create value for our company and our shareholders at every step of incremental success we make on the path to FDA approval.</p>
                </div>
                <div class="lg:col-span-6">
                    <p>
                        From discovery, to optimization, to pre-clinical trials, and additional future phases (phase 1 clinical trials, phase 2 clinical trials, phase 3 clinical trials), every step is a value inflection point that CancerVax believes could increase the company’s value and bring it one step closer to curing cancer.
                        <br><br> Join CancerVax and invest in our breakthrough technologies to help beat cancer!
                    </p>
                </div>
            </div>
            <div class="mt-6 sm:mt-24 mb-6">
                <h5 class="text-[23px] md:text-[34px] font-semibold">The Team </h5>
            </div>
            <div class="hidden sm:block"> <img src="assets/images/offer-team.jpg" alt="hero" class="w-full"></div>
            <div class="sm:hidden"> <img src="assets/images/Mobile_Team.png" alt="hero" class="w-full"></div>
        </div>
    </div>
</section>

    <!-- 6th Section -->
<section class="py-3 md:py-12">
    <div class="container">
        <h4 class="text-[23px] sm:text-[28px] font-medium leading-none mb-9">Terms</h4>
        <div class="p-6 md:p-9 mb-10 md:mb-24 rounded-[10px] shadow-[0_6px_10px_4px_rgba(0,0,0,0.15)]">
            <div class="text-[23px] sm:text-[28px] font-semibold leading-none mb-10 text-custom-teal-100 text-center lg:text-left lg:ml-[28%]">Overview</div>
            <div class="grid grid-cols-1 md:grid-cols-6 gap-6"> 
                <div></div>
                <div class="col-span-2">
                    <div class="text-base sm:text-lg font-normal leading-tight mb-1">OFFERING SIZE</div>
                    <div class="text-base sm:text-xl font-semibold leading-tight mb-7 md:mb-10">$5,000,000</div>
                    <div class="text-base sm:text-lg font-normal leading-tight mb-1">PRICE FOR SHARE</div>
                    <div class="text-base sm:text-xl font-semibold leading-tight mb-7 md:mb-10">$2.10</div>
                    <div class="text-base sm:text-lg font-normal leading-tight mb-1">MIN INVESTMENT</div>
                    <div class="text-base sm:text-xl font-semibold leading-tight mb-7">$525</div>
                </div>
                <div></div>
                <div class="col-span-2">
                    <div class="text-base sm:text-lg font-normal leading-tight mb-1">OFFERING TYPE</div>
                    <div class="text-base sm:text-xl font-semibold leading-tight mb-7 md:mb-10">Equity</div>
                    <div class="text-base sm:text-lg font-normal leading-tight mb-1">ASSET TYPE</div>
                    <div class="text-base sm:text-xl font-semibold leading-tight mb-7 md:mb-10">Common Stock</div>
                    <div class="text-base sm:text-lg font-normal leading-tight mb-1">SHARES OFFERED</div>
                    <div class="text-base sm:text-xl font-semibold leading-tight mb-7">Common Stock</div>
                </div>
            </div>
        </div>
        <h4 class="text-[23px] sm:text-[28px] font-medium leading-none mb-2">Bonus Shares</h4>
        <h3 class="text-[23px] md:text-[42px] font-medium leading-none mb-2">Invest More And Get More!</h3>
        <p class="text-[17px] font-normal leading-[23px] tracking-normal">Investors in this offering are eligible to receive bonus shares of Common Stock, which effectively gives them a discount on their investment.  Investors receiving the Bonus Shares will pay an effective price less than the $2.10 offering price.</p>
        <div class="mt-9 mb-11 md:mt-12 md:mb-20 rounded-[10px] shadow-xl overflow-hidden">
            <table class="w-full table-fixed lg:table-auto border-collapse">
                <thead class="[&_th]:text-base [&_th]:md:text-xl [&_th]:text-center [&_th]:font-semibold [&_th]:bg-black [&_th]:text-custom-white-100 [&_th]:px-4 [&_th]:py-4 [&_th]:md:px-4 [&_th]:md:py-6">
                    <tr>
                        <th>Total Investment</th>
                        <th>Bonus Shares</th>
                        <th>Effective Price Per Share</th>
                    </tr>
                </thead>
                <tbody class="[&_td]:text-base [&_td]:text-center [&_td]:font-medium [&_td]:px-4 [&_td]:py-4 [&_td]:md:px-4 [&_td]:md:py-6 [&_td]:border-b [&_td]:border-gray-100">
                    <tr>
                        <td>$1,000</td>
                        <td>5% Bonus Shares</td>
                        <td>$2.00</td>
                    </tr>
                    <tr>
                        <td>$1,500</td>
                        <td>7.5% Bonus Shares</td>
                        <td>$1.95</td>
                    </tr>
                    <tr>
                        <td>$2,500</td>
                        <td>10% Bonus Shares</td>
                        <td>$1.91</td>
                    </tr>
                    <tr>
                        <td>$5,000</td>
                        <td>15% Bonus Shares</td>
                        <td>$1.83</td>
                    </tr>
                    <tr>
                        <td>$10,000</td>
                        <td>20% Bonus Shares</td>
                        <td>$1.75</td>
                    </tr>
                    <tr>
                        <td>$25,000</td>
                        <td>25% Bonus Shares</td>
                        <td>$1.68</td>
                    </tr>
                    <tr>
                        <td>$35,000</td>
                        <td>30% Bonus Shares</td>
                        <td>$1.62</td>
                    </tr>
                </tbody>
            </table>
        </div>
        <h4 class="text-[23px] sm:text-[28px] font-medium leading-none mb-2">Updates</h4>
        <div class="text-3xl md:text-5xl font-bold leading-none my-7 md:mt-12 md:mb-24 text-center text-custom-gray-300 md:text-black">Placeholder</div>
        <h4 class="text-[23px] sm:text-[28px] font-medium leading-none mb-2">Market Statistics</h4>
        <div class="mb-2 [&_a]:underline">
            <a href="https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html" target="_blank">
                1. (2022) American Cancer Society
            </a>
        </div>
        <div class="mb-2 [&_a]:underline">
            <a href="https://www.globenewswire.com/news-release/2023/08/16/2726224/0/en/Oncology-Drugs-Market-Size-to-Surpass-USD-484-32-Billion-by-2030-exhibiting-a-CAGR-of-13-0.html" target="_blank">
                2. (2023) Fortune Business Insights
            </a>
        </div>
        <div class="mb-2 [&_a]:underline">
            <a href="https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2022.html" target="_blank">
                3.(2022) American Cancer Society
            </a>
        </div>
        <div class="mb-2 [&_a]:underline">
            <a href="https://www.statista.com/statistics/1313989/projection-on-cancer-care-costs-us/" target="_blank">
                4. (2023) Statista
            </a>
        </div>
        <div class="mb-2 [&_a]:underline">
            <a href="https://www.precedenceresearch.com/biotechnology-market" target="_blank">
                5. (2023) Precedence Research
            </a>
        </div>
        <h4 class="text-[23px] sm:text-[28px] font-medium leading-none mb-2 mt-12">Disclaimer</h4>
        <div class="[&_p]:text-[17px] [&_p]:font-normal [&_p]:leading-[23px] [&_p]:mb-8 [&_p]:tracking-normal">
            <p> 
                THESE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARDLOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS
                “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING
                STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
            </p>
            <p> PLEASE NOTE INVESTORS IN THIS OFFERING WILL BE CLIENTS OF THE ISSUER AND NOT DALMORE GROUP, LLC (“DALMORE”), A REGISTERED BROKER-DEALER AND MEMBER FINRA/SIPC. DALMORE’S ROLE IN THE TRANSACTION IS TO FACILITATE BACK OFFICE AND REGULATORY FUNCTIONS RELATED TO THE REGULATION A TRANSACTION, AND ACTS ONLY AS THE BROKER/DEALER OF RECORD FOR THE OFFERING LISTED. DALMORE IS NOT PROVIDING INVESTMENT ADVICE OR RECOMMENDATIONS, OR LEGAL OR TAX ADVICE.</p>
            <p> 
                AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. THE OFFERING CIRCULAR
                THAT IS PART OF THAT OFFERING STATEMENT IS AT: [INSERT LINK TO S-1A FILING W SEC]
            </p>
            <p> 
                DALMORE GROUP LLC’S, ROLE IN REG A OFFERINGS ARE LIMITED TO SERVING AS THE BROKER-DEALER OF RECORD. IN THIS CAPACITY DALMORE POVIDES VERY NARROW AND SPECIFIC SERVICES TO THE ISSUERS AND INVESTORS, WHICH DOES NOT INCLUDE INVESTMENT RECOMMENDATIONS IN ANY CAPACITY. IT'S IMPORTANT THAT DALMORE GROUP LLC EMPHASIZES IT IS NOT ENGAGED IN THE PLACEMENT OR SALE OF THESE SECURITIES ON BEHALF OF THE ISSUER., NOR IS IT ACTIVELY SEEKING INVESTMENTS FOR THE ISSUER OR FURNISHING RECOMMENDATIONS. RATHER, THEIR INVOLVEMENT REVOLVES AROUND THE METICULOUS <br>
                COLLECTION, ASSESmdENT, AND PROCESSING OF AN INVESTOR'S DOCUMENTATION FOR THIS INVESTMENT OPPORTUNITY. NOTABLY, DALMORE GROUP LLC DILIGENTLY UNDERTAKES ANTI-MONEY LAUNDERING, IDENTITY, AND BAD ACTOR DISQUALIFICATION REVIEWS OF THE ISSUER, AND VERIFIES THEIR STATUS AS A REGISTERED AND LEGITIMATE BUSINESS ENTITY. HOWEVER, IT'S ESSENTIAL TO UNDERSTAND THAT DALMORE GROUP LLC DOES NOT UNDERTAKE THE TASK
                OF EVALUATING OR ENDORSING THE INFORMATION PROVIDED BY THE ISSUER OR THE ISSUER ITSELF.
            </p>
            <p> PLEASE REFER TO DALMORE GROUP, LLC’S CONTACT DETAILS FOR INVESTOR INQUIRIES AND REQUESTS PERTAINING TO REGULATION A IN GENERAL, OR THE SPECIFIC STATUS OF SUBMITTED DOCUMENTATION. IN RESPONSE DALMORE GROUP LLC MAY GUIDE INVESTORS TO PERTINENT SECTIONS WITHIN THE OFFERING CIRCULAR TO LOCATE THE INFORMATION OR ANSWERS TO THEIR QUERIES. PLEASE BE MINDFUL THAT DALMORE GROUP LLC REFRAINS FROM RENDERING OPINIONS OR GUIDANCE CONCERNING ISSUER-RELATED MATTERS.</p>
        </div>
    </div>
</section>

    <!-- 7th Section -->
<section>
    <div class="bg-custom-gray-100">
        <div class="container">
            <div class="py-10 md:py-20 grid grid-cols-1 md:grid-cols-12 md:gap-6">
                <div class="md:col-span-7">
                    <div class="text-base md:text-3xl font-bold text-center md:text-left mb-5">Keep up with our progress by subscribing to
                        our email newsletter!
                    </div>
                </div>
                <div class="md:col-span-5 relative">
                    <form action="https://submit.jotform.com/submit/242775392698071/" method="POST" class="email-input">
                        <input type="hidden" name="formID" value="242775392698071" />
                        <input type="email" id="input_3" name="q3_email" class="w-full border border-custom-teal-100 text-base font-normal p-[10px] rounded-md min-h-[50px] pr-[120px] hidden md:block" placeholder="Enter your email">
                        <div class="mt-16 md:mt-2" data-type="control_captcha" id="id_4">
                            <label class="text-[15px] font-normal leading-6" id="label_4" for="input_4" aria-hidden="false"> Please verify that you are human<span>*</span> </label>
                            <div id="cid_4" class="form-input-wide jf-required" data-layout="full">
                                <section data-wrapper-react="true">
                                    <div id="hcaptcha_input_4" class="h-captcha" data-siteKey="772f4a50-7161-425e-8cd5-4d7e361ab765" data-callback="hcaptchaCallbackinput_4" data-expired-callback="hcaptchaExpiredCallbackinput_4"></div><input type="hidden" id="input_4" class="hidden validate[required]" name="hcaptcha_visible" required="" />
                                    <script type="text/javascript" src="https://hcaptcha.com/1/api.js"></script>
                                </section>
                            </div>
                        </div>
                        <button type="submit" id="submitNewsletterButton" class="bg-custom-teal-100 text-custom-white-100 cursor-pointer p-[10px] text-xl font-medium border-none rounded-md min-h-[50px] w-full md:w-fit absolute top-0 right-0">Subscribe</button>
                    </form>
                    <script>
                        const submitNewsletterButton = document.getElementById('submitNewsletterButton');

                        function onCaptchaSuccess(token) {
                            document.getElementById('input_4').value = token;
                            submitNewsletterButton.disabled = false;
                        }

                        function onCaptchaExpired() {
                            document.getElementById('input_4').value = '';
                            submitNewsletterButton.disabled = true;
                        }
                    </script>
                    <div class="text-xs font-medium my-2">We care about your data in our privacy policy</div>
                </div>
            </div>
        </div>
    </div>
</section>